NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
Back to search
Official data from USPTO
TRANSIRNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSIRNA
ST13
US500000090272202Class
1, 5, 42
Filing
90272202
Registration
7342045
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
04/02/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/22/2020
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
SUWON-SI, GYEONGGI-DO, KR
Examiner
CALLERY, TIMOTHY
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMNEWRUN, INC.
Imnewrun Biosciences, Inc.
Representatives
Lenny R. Jiang PARATUS LAW GROUP, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
preparations for gene recombination for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; preparations for nucleic acid for scientific or laboratory purposes; oligopeptides for use in the manufacture of cosmetics; peptide substrates for scientific purposes
Class 5
preparations for gene recombination for medical purposes; oligonucleotides for medical purposes; recombinant nucleic acid for medical purposes; nucleic acid for medical purposes; preparations for nucleic acid for medical purposes; medicated scalp treatments; medicated lotions and creams for the bodyskinfacehands; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated skin care preparations; pharmaceutical preparations for treating epidermal problems
Class 42
research and development of technology for biotechnology; scientific research in the fields of biomedicine; pharmaceutical products development; medical studies; medicine research; testinginspection or research of pharmaceuticalscosmetics or foodstuff; laboratory research in the field of biology; development of biologics; laboratory research in the field of gene expression; scientific research for medical purposes; research and development of amino acid for medical purposes; research and development of peptide for medical purposes; research and development of oligonucleotides for medical purposes; research and development of technology for medicinal chemical manufacturing
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2022
ALIE
ASSIGNED TO LIE
03/30/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/22/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/08/2021
GNSL
LETTER OF SUSPENSION E-MAILED
10/08/2021
CNSL
SUSPENSION LETTER WRITTEN
10/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/13/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2021
GNRT
NON-FINAL ACTION E-MAILED
03/24/2021
CNRT
NON-FINAL ACTION WRITTEN
03/24/2021
DOCK
ASSIGNED TO EXAMINER
03/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2020
NWAP
NEW APPLICATION ENTERED
10/26/2020
Continuous trademark protection
Get notified about every new filing that threatens TRANSIRNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.